Cogentix Home Revenue and Competitors
Estimated Revenue & Valuation
- Cogentix Home's estimated annual revenue is currently $4.5M per year.
- Cogentix Home's estimated revenue per employee is $112,000
Employee Data
- Cogentix Home has 40 Employees.
- Cogentix Home grew their employee count by 11% last year.
Cogentix Home's People
Name | Title | Email/Phone |
---|---|---|
1 | Quality Engineer | Reveal Email/Phone |
Cogentix Home Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $14.1M | 101 | 5% | N/A | N/A |
#2 | $1.6M | 19 | -71% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 54 | 8% | N/A | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 599 | -17% | $2.3M | N/A |
#8 | $35.6M | 231 | 6% | N/A | N/A |
#9 | $38.3M | 249 | 5% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is Cogentix Home?
Cogentix Medical, Inc. is a global medical device company that develops, manufactures and markets products for the minimally invasive treatment of voiding dysfunctions and endoscopy solutions. Please visit www.cogentixmedical.com for full product and safety information. Cogentix Medical products are for prescription use only. Cogentix Medical's products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. EndoSheath® Endoscopy combines state-of-the-art endoscopic technology with a sterile, disposable microbial barrier, provides practitioners and healthcare facilities with a solution to meet the growing need for safe, efficient, and cost-effective flexible endoscopy.
keywords:N/AN/A
Total Funding
40
Number of Employees
$4.5M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cogentix Home News
Home/News/Bowel Management System Market Size, Scope And Outlook | Coloplast, B. Braun, C.R. Bard, Axonics Modulation Technologies, Cogentix...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.6M | 40 | 5% | N/A |
#2 | $5.8M | 40 | 0% | N/A |
#3 | $7.8M | 40 | 3% | N/A |
#4 | $4.8M | 40 | 8% | N/A |
#5 | $10.5M | 41 | 14% | N/A |